Knowledge hub

Knowledge hub
News

New Publication on Decoding Phenotypic Screening: A Collaborative Effort with Janssen Pharmaceutica and Jagiellonian University

Ardigen Appoints New CCO to Accelerate Growth Plans and Become the Top AI CRO Worldwide
The New Issue of the OncoDecalogue Series is Now Available to Download for Free
Ardigen and Selvita Now Offer Joint Cell Painting Services
Resounding Success of OncoActive Days 2023 
New Paper Released by Ardigen and Collaborators: Advances in AI – Powered Histological Evaluation of Crohn’s Disease and Ulcerative Colitis
Code Against Cancer’s “ONCOdecalogue of Emotions” Receives Acclaim at PTPO Conference
Ardigen Celebrates 8 Years of Innovation in AI Drug Discovery
Ardigen Teams Join Forces at the 12th “Poland Business Run”
News

Ardigen Collaborates on Breakthrough in TCR Therapy Advancements

Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska
Ardigen Representatives Share Expertise with Silesian University of Technology Students
Leave Your Trace Foundation and Ardigen Unveil “ONCODecalogue of Emotions” for Children Facing Health Challenges
Hackathon – March 2023
Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Ardigen at SLAS International Conference & Exhibition 2023
Meet Ardigen phenAID platform
Ardigen at PMWC 2023
  • Services
  • Technology
Social Media
United States

611 Gateway Boulevard
South San Francisco, CA 94080
USA
tel.+1 628 200 09 14

One Broadway, 14th Floor
Cambridge, MA 02142
USA
tel.+1 628 200 09 14

European Union

Sternbacha 1
30-394 Kraków
Poland
tel.+48 12 340 94 94